129 related articles for article (PubMed ID: 6305668)
1. Vindesine in advanced renal cancer. A study of the EORTC Genito-urinary Tract Cancer Cooperative Group.
Fosså SD; Denis L; van Oosterom AT; de Pauw M; Stoter G
Eur J Cancer Clin Oncol; 1983 Apr; 19(4):473-5. PubMed ID: 6305668
[TBL] [Abstract][Full Text] [Related]
2. Vindesine for metastatic malignant melanoma. A phase II trial.
Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of vindesine in patients with advanced breast cancer.
Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
[TBL] [Abstract][Full Text] [Related]
4. Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity.
Pazdur R; Rossof AH; Chandra G; Bonomi PD; Slayton RE; Wolter J
Cancer Chemother Pharmacol; 1982; 9(1):41-4. PubMed ID: 7139851
[TBL] [Abstract][Full Text] [Related]
5. Vindesine in the treatment of metastatic breast cancer.
Hansen PV; Brincker H
Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1221-5. PubMed ID: 6541581
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma.
Wong PP; Yagoda A; Currie VE; Young CW
Cancer Treat Rep; 1977 Dec; 61(9):1727-9. PubMed ID: 340038
[No Abstract] [Full Text] [Related]
7. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
[TBL] [Abstract][Full Text] [Related]
8. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
Diaz-Rubio E; Martin-Jimenez M
Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
[No Abstract] [Full Text] [Related]
9. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone in advanced renal cancer: a phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
van Oosterom AT; Fosså SD; Pizzocaro G; Bergerat JP; Bono AV; De Pauw M; Sylvester R
Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1239-41. PubMed ID: 6541582
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy of carcinoma of the respiratory and digestive tracts with vindesine sulfate. Phase II clinical trial].
Domenge C; Richard JM
Ann Otolaryngol Chir Cervicofac; 1984; 101(2):119-21. PubMed ID: 6372615
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
[No Abstract] [Full Text] [Related]
13. An EORTC phase II study of vindesine in advanced prostate cancer.
Jones WG; Fosså SD; Denis L; Coninx P; Glashan RW; Akdas A; De Pauw M
Eur J Cancer Clin Oncol; 1983 May; 19(5):583-8. PubMed ID: 6683629
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study.
Mulder JH; Dodion P; Cavalli F; Czarnetzki B; Clavel M; Thomas D; Suciu S; Rozencweig M
Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1297-301. PubMed ID: 6891928
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of vindesine in advanced gastric cancer.
Kenny JB; Scarffe JH; Maley WV
Cancer Treat Rep; 1983 Jan; 67(1):89-90. PubMed ID: 6311414
[No Abstract] [Full Text] [Related]
16. Phase II study of vindesine in patients with metastatic breast cancer.
Cobleigh MA; Williams SD; Einhorn LH
Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
[TBL] [Abstract][Full Text] [Related]
17. Treatment of esophageal cancer with vindesine: an open trial.
Bezwoda WR; Derman DP; Weaving A; Nissenbaum M
Cancer Treat Rep; 1984 May; 68(5):783-5. PubMed ID: 6722833
[TBL] [Abstract][Full Text] [Related]
18. Vindesine in the treatment of squamous cell carcinoma (WHO I), adenocarcinoma (WHO III), and large cell carcinoma (WHO IV) of the lung.
Ferrazzi E; Zagonel V; Vinante O; Galligioni E; Pappagallo GL; Cartei G; Fiorentino MV
Tumori; 1982 Dec; 68(6):531-5. PubMed ID: 6301122
[TBL] [Abstract][Full Text] [Related]
19. Initial clinical studies of vindesine.
Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.
Fuks JZ; Egorin MJ; Aisner J; Van Echo DA; Ostrow S; Bachur NR; Wiernik PH
Cancer Chemother Pharmacol; 1983; 10(2):104-8. PubMed ID: 6299598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
